Welcome to our dedicated page for National Health Investors news (Ticker: NHI), a resource for investors and traders seeking the latest updates and insights on National Health Investors stock.
National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust (REIT) established in 1991, specializing in sale-leasebacks, joint ventures, and both mortgage and mezzanine financing. The company's primary focus is on need-driven and discretionary senior housing and medical investments.
NHI's diverse portfolio comprises various types of facilities including independent living, assisted living, and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings, and specialty hospitals. The company operates through two main segments: Real Estate Investments and the Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment includes investments in real estate leases, mortgages, and other notes receivables related to independent living, assisted living, and skilled nursing facilities among others. The SHOP segment involves ventures that own and operate independent living facilities, realizing revenue from rental, mortgage interest income, and resident fees and services.
Financially, NHI has demonstrated resilience and growth. As of the end of 2023, NHI maintained a robust balance sheet with $1.1 billion in net debt and leverage at just 4.4 times net debt-to-adjusted EBITDA. This strong financial profile is enhanced by investment-grade credit ratings from Moody's, S&P Global, and Fitch Ratings. NHI's financial health was further highlighted by the company exceeding its 2023 guidance for NAREIT FFO, NFFO, and FAD.
Recent achievements include a successful fourth quarter in 2023 with over $2.0 million in deferral repayments, no unexpected rent concessions, and substantial growth in the SHOP segment. The company has continued this momentum into 2024, generating notable revenue growth and maintaining high occupancy rates across its facilities. Looking ahead, NHI has a pipeline exceeding $300 million, with a significant portion already under letters of intent, ensuring ongoing investment and growth opportunities.
In February 2024, NHI announced a new stock repurchase plan totaling $160 million, reflecting its commitment to returning value to shareholders. The company also maintains a substantial revolving credit facility, offering significant liquidity for future investments and operational needs.
Partnerships and Programs:
- Strategic partnerships with senior housing operators.
- Joint ventures for operational and financial synergy.
- Investment in high-yield real estate opportunities.
NHI’s commitment to long-term growth and stable financial health, combined with its strategic investment in senior housing and medical facilities, positions it as a vital player in the healthcare real estate market.
For more information, visit www.nhireit.com.
National Health Investors (NYSE:NHI) has announced the pricing of an upsized public offering of 2,400,000 shares of common stock at $71.25 per share. The offering, expected to close on August 16, 2024, includes a 30-day option for underwriters to purchase up to 360,000 additional shares. NHI has entered into forward sale agreements with major financial institutions, allowing for future settlement within approximately 12 months. The company plans to use the net proceeds for working capital, acquisitions, debt repayment, and mortgage investments. This offering is made through an effective shelf registration statement and is being managed by leading investment banks.
National Health Investors (NYSE:NHI) has announced a public offering of 2,000,000 shares of its common stock. The offering includes a 30-day option for underwriters to purchase up to an additional 300,000 shares. NHI will enter into forward sale agreements with major financial institutions acting as forward purchasers. The company won't receive immediate proceeds from the sale but expects to settle the agreements within 12 months for cash. NHI plans to use the net proceeds for working capital, acquisitions, debt repayment, and mortgage investments. The offering is made under an effective shelf registration statement and will be conducted through a prospectus supplement and related documents available from the joint book-running managers: BofA Securities, J.P. Morgan, Wells Fargo Securities, and BMO Capital Markets.
National Health Investors (NYSE:NHI) has declared its third quarter 2024 dividend of $0.90 per common share. The dividend will be paid on November 1, 2024 to stockholders of record as of September 27, 2024. This announcement demonstrates NHI's commitment to providing regular returns to its shareholders, maintaining its dividend policy despite ongoing economic uncertainties. The consistency in dividend payments may be seen as a positive sign of the company's financial stability and confidence in its future performance.
National Health Investors, Inc. (NYSE:NHI), a real estate investment trust specializing in senior housing and medical investments, has issued an investor update. The update is available on the company's website under the 'Presentations and Webcasts' section. NHI's portfolio includes various types of senior living facilities such as independent living, assisted living, memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
NHI, founded in 1991, focuses on sale-leasebacks, joint ventures, senior housing operating partnerships, and mortgage and mezzanine financing for need-driven and discretionary senior housing and medical investments. This update provides investors with the latest information about the company's operations and performance.
National Health Investors (NYSE:NHI) announced its Q2 2024 results, showing improved performance compared to the previous year. Key highlights include:
- Net income per diluted share: $0.81 (Q2 2024) vs $0.92 (Q2 2023)
- NAREIT FFO per diluted share: $1.18 (Q2 2024) vs $1.05 (Q2 2023)
- Normalized FFO per diluted share: $1.18 (Q2 2024) vs $1.06 (Q2 2023)
- Normalized FAD: $51.8 million (Q2 2024) vs $44.6 million (Q2 2023)
NHI updated its 2024 guidance, raising NAREIT FFO, Normalized FFO, and Normalized FAD ranges. The company reported increased rental income, higher SHOP NOI, and new investments totaling $56.6 million with an 8.4% average initial yield. NHI also has $155.4 million in signed LOIs with an 8.4% average yield and is evaluating $270 million in potential investments.
National Health Investors (NYSE:NHI) has announced the schedule for its second quarter 2024 earnings release and conference call. The company will release its Q2 2024 results after market close on Tuesday, August 6, 2024. A conference call to discuss the results is scheduled for Wednesday, August 7, 2024, at 11:00 a.m. Eastern Time.
Investors and analysts can participate in the interactive teleconference by calling (888) 506-0062 with the confirmation number 781474. Additionally, a live broadcast of the conference call will be available online at www.nhireit.com and https://www.webcaster4.com/Webcast/Page/633/50711. An online replay of the call will be accessible shortly after the live broadcast and will remain available for one year.
National Health Investors, Inc. (NHI) filed a supplemental proxy statement with the SEC detailing steps taken by the Board of Directors in response to stockholders' concerns. The Board plans to propose amending the Articles of Incorporation, search for a new director, and evaluate Board composition.
National Health Investors, Inc. (NYSE:NHI) will pay a second quarter dividend of $0.90 per common share on August 2, 2024, to stockholders of record as of June 28, 2024.
National Health Investors, Inc. (NYSE:NHI) has issued an investor update focusing on their real estate investments in senior housing and medical facilities. NHI's diverse portfolio includes various types of healthcare properties. For more details, visit their website.
National Health Investors, Inc. (NYSE:NHI) announced its Q1 2024 results, showing net income per share of $0.71, NAREIT FFO per share of $1.10, and Normalized FFO per share of $1.12. The company updated its 2024 annual guidance and reported various financial figures. NHI's CEO highlighted deferral repayments, revenue growth, and raised guidance for the full year, emphasizing internal growth potential and financial strength.
FAQ
What is the current stock price of National Health Investors (NHI)?
What is the market cap of National Health Investors (NHI)?
What types of properties are included in NHI's portfolio?
How does NHI generate its revenue?
What are the main segments of NHI's operations?
How has NHI performed financially in recent years?
What recent achievements has NHI made?
What is the 2024 stock repurchase plan?
What are NHI's plans for future investments?
How does NHI maintain its financial stability?
Who comprises NHI’s primary tenant base?
How can investors learn more about NHI?
